Pfizer Inc.’s Covid-19 pill gets for emergency use approval in US

(G.N.S) dt. 23 Washington United States has authorized Pfizer Inc’s (PFE.N) antiviral COVID-19 pill for people ages 12 and older at risk of severe illness, the first oral and at-home treatment as well as a new tool against the fast-spreading Omicron variant. Pfizer’s antiviral regimen, Paxlovid, was nearly 90% effective